文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

2021-2022年印第安纳州不同年龄组已接种疫苗与既往感染个体的SARS-CoV-2感染、住院和死亡情况

SARS-CoV-2 Infection, Hospitalization, and Death in Vaccinated and Infected Individuals by Age Groups in Indiana, 2021‒2022.
PubMed 文献 · Am J Public Health · 2023-01-01

研究将印第安纳州至少接种1剂SARS-CoV-2疫苗者与既往SARS-CoV-2感染者按索引日期、年龄、性别、种族/族裔、邮政编码和临床诊断进行匹配,比较感染、全因急诊就诊、住院和死亡的累积发生率。共匹配267847对个体。索引日期后6个月,疫苗接种者SARS-CoV-2感染发生率(6.7%)显著高于既往感染者(2.9%),但疫苗接种者全因死亡率较既往感染者低37%,全因急诊就诊率和住院率分别低24%和37%。结论认为疫苗接种者全因急诊就诊、住院和死亡率显著较低,凸显疫苗的实际益处,并对有安全有效疫苗时依赖自然免疫的明智性提出疑问。

要点

  • 匹配267847对个体,索引日期后6个月感染发生率疫苗接种者6.7% vs 既往感染者2.9%。
  • 疫苗接种者全因死亡率较既往感染者低37%。
  • 疫苗接种者全因急诊就诊率和住院率分别较既往感染者低24%和37%。

核心结论

  • 疫苗接种者全因急诊就诊、住院和死亡率显著低于既往感染者,凸显疫苗的实际益处;数据对有安全有效疫苗时依赖自然免疫的明智性提出疑问。

研究设计与样本

  • 结合全州检测和免疫数据与患者医疗记录,将至少接种1剂SARS-CoV-2疫苗者与既往SARS-CoV-2感染者按索引日期、年龄、性别、种族/族裔、邮政编码和临床诊断进行匹配,共匹配267847对个体,比较感染、全因急诊就诊、住院和死亡的累积发生率。

主要发现

  • 索引日期后6个月,SARS-CoV-2感染发生率疫苗接种者为6.7%,既往感染者为2.9%,疫苗接种者显著更高。
  • 疫苗接种者全因死亡率较既往感染者低37%。
  • 疫苗接种者全因急诊就诊率较既往感染者低24%,全因住院率较既往感染者低37%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives. To assess the effectiveness of vaccine-induced immunity against new infections, all-cause emergency department (ED) and hospital visits, and mortality in Indiana. Methods. Combining statewide testing and immunization data with patient medical records, we matched individuals who received at least 1 dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines with individuals with previous SARS-CoV-2 infection on index date, age, gender, race/ethnicity, zip code, and clinical diagnoses. We compared the cumulative incidence of infection, all-cause ED visits, hospitalizations, and mortality. Results. We matched 267 847 pairs of individuals. Six months after the index date, the incidence of SARS-CoV-2 infection was significantly higher in vaccine recipients (6.7%) than the previously infected (2.9%). All-cause mortality in the vaccinated, however, was 37% lower than that of the previously infected. The rates of all-cause ED visits and hospitalizations were 24% and 37% lower in the vaccinated than in the previously infected. Conclusions. The significantly lower rates of all-cause ED visits, hospitalizations, and mortality in the vaccinated highlight the real-world benefits of vaccination. The data raise questions about the wisdom of reliance on natural immunity when safe and effective vaccines are available. (Am J Public Health. 2023;113(1):96-104. https://doi.org/10.2105/AJPH.2022.307112).

来源:Am J Public Health,查看原文。版权归原作者所有。

引用

  1. Tu W, Zhang P, Roberts A, et al. SARS-CoV-2 Infection, Hospitalization, and Death in Vaccinated and Infected Individuals by Age Groups in Indiana, 2021‒2022. Am J Public Health. 2023. PMID: 36516380. doi:10.2105/AJPH.2022.307112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。